drugset / Trial / NCT04231084
Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide
RandomizedCrossoverTriple-blindDiagnostic
Summary
The overarching goal of this study is to examine the acute vasoreactive response to both inhaled nitric oxide and inhaled epoprostenol across both traditionally and non-traditionally interrogated phenotypes in PH, and to further characterize the relationship of vasoreactivity to disease severity and PH phenotype.
Timeline
- Start
- 2021-01-15
- Primary completion
- 2024-08-01
- Completion
- 2024-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nitric Oxide | Other / unclassified | — | Inhaled |
| Subject | epoprostenol | Other / unclassified | — | Inhaled |